Purchase Order 75F40123P00101

Award Date 5/10/23
Potential Completion Date 8/11/28
Potential Value $214K
Ultimate Awardee
Bruker Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Jefferson, AR 72079, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $120,290.40 firm-fixed-price purchase order to Bruker Biospin Corp, a manufacturer of scientific instruments, for a Cryoprobe/Cryoplatform System Service Agreement. The contract provides for the maintenance and support of specialized cryogenic cooling equipment used in the agency's research and testing programs. This award is not associated with a larger contract vehicle and does not have a set-aside...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for cryo-cooler servicing and preventative maintenance. The contract has a ceiling value of $76,735.93 and an ultimate completion date of August 11, 2023. Bruker Biospin Corp is a manufacturer of scientific instruments and provides specialized equipment, maintenance, and support services to U.S. federal government agencies, including the FDA,...
This is a firm fixed price purchase order for a cryo-cooling unit awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and provider of specialized equipment, maintenance, and support services to U.S. federal government agencies. The unit is for a Bruker NMR spectrometer system at the FDA's National Center for Toxicological Research. The potential value of the contract is $116,955.00 and there was no...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for $168,657.46 to provide service and maintenance for a Bruker Biospec 70/30 magnetic resonance imaging (MRI) cooler and cold head. The contract has a completion date of August 31, 2022. Bruker Biospin Corp is a manufacturer of scientific instruments and provides specialized equipment, maintenance, and support services...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services' Food and Drug Administration to Bruker Biospin Corp for maintenance of laboratory equipment. The $180,527.72 contract provides for a two-year agreement covering console, magnet, cryoplatform, and two cryoprobes used for nuclear magnetic resonance spectroscopy. Performance will take place at a laboratory in Jamaica, New York. As the prime and sole contractor, Bruker Biospin Corp will be responsible...
This contract was awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for a pre-inspection, cryocooler servicing, and preventative maintenance service contract on a Bruker Biospec 47/40 magnetic resonance imaging (MRI) unit. The contract has a ceiling value of $91,353.96 and is a firm fixed-price purchase order. It does not utilize any set-aside program. The contract was awarded on August 12, 2021, with a final completion date of August...
The U.S. Food and Drug Administration (FDA) awarded a $36,020 firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for preventive maintenance and repair services for the cryo-cooler components of a Bruker Biospec 47/40 magnetic resonance imaging (MRI) unit located at the National Center for Toxicological Research (NCTR) in Jefferson, AR. The contract includes one scheduled on-site preventive maintenance service per year, unlimited on-site corrective...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and equipment, for the delivery of a Cryo Probe for Nuclear Magnetic Resonance (NMR) analysis. The contract has a potential value of $187,725.00 and a completion date of December 31, 2020. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support...
This is a $159,767.50 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for the provision of a Bruker Avance III 500 MHz Nuclear Magnetic Resonance (NMR) system. The contract has no set-aside designation and is for the service and maintenance of this specialized scientific equipment used by the FDA. Bruker Biospin Corp has a history of providing NMR systems, upgrades, and support services...
Bruker Biospin Corp, a manufacturer of scientific instruments and subsidiary of Bruker Corporation, has been awarded a firm fixed price purchase order totaling $210,321.52 by the Department of Health and Human Services' Food and Drug Administration. The contract is for preventative maintenance and repair services for a Bruker Avance III 600 MHz nuclear magnetic resonance spectrometer located in Jamaica, New York through December 18, 2022. No set-aside designation was used for this award to...

The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Bruker Biospin Corp for a preventive maintenance and repair service agreement for cryo-cooler components of Bruker BioSpin 47/40 systems. Valued at two hundred fourteen thousand one hundred eighty-five dollars, this contract supports maintenance of cryogenic cooling equipment through August 2028 without a set-aside designation. As a manufacturer of scientific instruments, Bruker Biospin Corp will provide maintenance and repair services for its own cryo-cooler components to the FDA, enabling continued operation of specialized magnetic resonance imaging technologies.

Generated 1/26/24, 10:14 AM